Hemolytic anemia primary prevention
|
Hemolytic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemolytic anemia primary prevention On the Web |
|
American Roentgen Ray Society Images of Hemolytic anemia primary prevention |
|
Risk calculators and risk factors for Hemolytic anemia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
There is a small role for preventive measures in hemolytic anemia. Primary prevention focuses on preventing the disease onset before the disease process begins. Avoidance of hemolysis triggers a primary prevention measure.
Primary Prevention
Primary prevention for hemolytic anemia includes avoidance of particular triggers for hemolysis. This includes:
- Avoidance of immunotherapeutic drugs
- Avoidance of unnecessary antibiotics like trimethoprim-sulfamethaxone[1]
- Avoidance of fava beans for patients who have G6PD deficiency[2]
- Use of bioprothetic cardiac valves over mechanical valves to prevent valve-induced hemolysis
References
- ↑ Thomas HL, Livesey MA (1998). "Immune-mediated hemolytic anemia associated with trimethoprim-sulphamethoxazole administration in a horse". Can Vet J. 39 (3): 171–3. PMC 1539918. PMID 9524723.
- ↑ Bottini E (1973). "Favism: current problems and investigations". J Med Genet. 10 (2): 154–7. PMC 1013006. PMID 4714581.